⚫️ Unfiltered Truth for the Modern-Day Orthopedic Professional ⚫️ Subscribe $1/day!

The Tiger Dashboard – July 2026

I’m sharing this month’s DASHBOARD—the same intelligence I use to track new startups currently punching above their weight, M&A and […]

🔴 Tiger’s Red-Hot Innovator of the Week – San Diego spine startup has created an integrated ecosystem for ASCs

Surgical hardware and digital intelligence are converging. In particular, we are watching ortho/spine market reach an inflection point, driven by

[Tiger’s Weekly Intel] – Some Startups found progress through acquisitions, FDA clearances, capital funding, and commercial momentum.

The past week highlighted key momentum across both U.S. and international orthopedic startups, marked by big M&A acquisitions, navigation clearances,

Agency.

Agency is the real prize. Not status. Not the title. Not the salary line that shrinks with inflation every year

How Ortho startups can break through the Hospital lockout.

Let’s face it. All the innovation in orthopedics comes from startups these days. However, your better technology and better outcomes

Founders Beware ! Funding scammers are targeting Medtech startups

This is really happening. Learn about it and beware. Let’s face it: the current capital-raising environment for early-stage orthopedic and

Financial Health: What to check before you join a new company.

This is important… and often overlooked. In orthopedics, we love to talk about clinical data, disruptive tech, and market opportunity.

The Strategy Behind the DePuy X-PAC Acquisition

DePuy Synthes announced its acquisition of Expanding Innovations (EI), officially bringing the X-PAC® expandable interbody platform under the DPY umbrella.

🔴 Tiger’s Red-Hot Innovator of the Week: UK startup brings predictive real-time protection to your knee.

This week we are shifting the Sports Med innovation discussion from passive bracing —> to predictive real-time knee protection. Historically,

[Tiger’s Weekly Intel] – M&A, Handheld Robotics, and 3D Biomimetic Implants Drive the Shift to ASC-Focused Outpatient Care

Most of the industry is reading self-serving press releases, but here is your intel for the week. The trend continues

How to torch $300M building a surgical robot company.

It is one of the most seductive pitches in modern venture capital: “We are going to disrupt Intuitive Surgical’s DaVinci.”

The Great Unbundling of Orthopedics Has Begun

For decades, the dominant orthopedic corporate strategy was portfolio consolidation—creating “one-stop-shop” conglomerates that could bundle joints, spine, trauma, and sports

The Brutal 10-Year Verdict: How Shaving the Meniscus Actually Ruins the Knee

Article Summary The orthopedic industry just got handed a 10-year bill it can’t ignore. For decades, arthroscopic partial meniscectomy was

🔴 Tiger’s Red-Hot Innovator of the Week – French startup simplifying ACJ stabilization with synthetic ligament.

I believe that we are entering the Sports Med wave with accelerating innovation in this space. Here is my scoring

[Tiger’s Weekly Intel] – VB Spine’s acquisition, Movmedix’s FDA clearance, and Miach’s clinical data.

Most of the industry is reading self-serving press releases, but here is your intel on what really happened last week.

The Reverse Total Hip — Promise, Perils, and the Data That Will Decide

We’ve all heard the drumbeat: total hip arthroplasty (THA) is a mature, commodity market. Implants are reliable, survival curves flatline

When the Race to the Bottom Lands You in the Power Tool Aisle

We often talk about implant “commoditization” in orthopedics. It’s that spooky campfire story that consultants use to scare medical sales

A quick dive into the 3 types of publicly traded Orthopedic companies.

Something different today. The orthopedic sector continues to showcase a fascinating divide of financial health. When looking at the public

Why Ortho innovation works better inside a Venture Studio

The traditional playbook for taking an idea to commercialization is broken. Historically, a surgeon has a great new product idea

Making sense of the ZB acquisition of iovera°

Tiger’s Strategic Summary ZB knows that implants are becoming commodities with an inevitable race to the bottom. ZB also knows

🔴 Tiger’s Red-Hot Innovator of the Week – Startup simplifying biceps tenodesis with sutureless anchor.

I believe that we are entering the Sports Med wave with accelerating innovation in this space. Below is my scoring of

[Tiger’s Weekly Intel] – Niche M&A, Startup Fundings, Pivots to AI Workflow and Localized Post-Surgical Pain Management.

Most of the industry is reading silly press releases, but here is your 7-day market update. Now that 2026 H1

Insights into the venture “bottom” for ortho innovators.

It’s been a rough few years for orthopedic innovators needed capital. My short summary of the capital allocators during this

Death of the Ortho Sales Rep (or how we lost our autonomy & our surgeons).

If you’ve been in the orthopedics game long enough, you remember the Golden Era. Thirty years ago, being an ortho

Why Ortho Startups Fail the Reimbursement Reality Test

What this article will teach you. Reimbursement isn’t a math problem; it’s a structural maze. Stop building your commercial strategy

The Equity Percentage Trap

You are looking at your offer letter from an early-stage orthopedic company. You can understand the base salary, the bonus

🔴 Tiger’s Red-Hot Innovator of the Week – Startup enhancing anchor outcomes with real-time AI Intelligence during surgery.

For decades, the sports medicine market has been defined by the same frustrating tradeoffs: mechanical weaknesses in repair setups, clunky

[Tiger’s Weekly Intel] – Mini-Tech, Micro-M&A, and Non-Invasive Interventions Disrupting Orthopedics

Most of the industry is reading silly press releases, but here is your 7-day market update. The shift continues. Ortho

How Silver Bullet is Weaponizing Healthcare Economics Against SSIs

We all know that surgical site infections (SSIs) are the ultimate nightmare in orthopedics. A flawlessly executed procedure can be

Inside the Quiet Ortho Revolution Happening North of the Border

For decades, the global orthopedic community has looked to the usual suspects for groundbreaking innovation: Warsaw, Indiana; Memphis, Tennessee; or

Before you sign: How to find hidden financial red flags at the company.

Joining a new orthopedic company is an exciting career move, but the medical device world carries unique financial risks. Long

Why independence won’t save DePuy Synthes

Johnson & Johnson will sell or spinout its $20B DePuy Synthes orthopedics business, and that tell-all number tells you absolutely

Tiger’s Red-Hot Innovator of the Week – Startup runs 30,000 digital simulations per patient to find the absolute perfect joint match.

Every Monday I share a startup that I really. I call it the Red-Hot Innovator of the Week. I am

[Tiger’s Weekly Intel] 👀 Big Ortho’s Broken R&D, $650M Cash Drops, and the Threat to the Legacy Robotics Footprint

Most of the industry is reading silly press releases, but here is your 7-day unredacted market update. The mega-trend in

Wearables Are About to Explode in Orthopedics

We all know that orthopedics lags other medical areas in real-time patient data collection. But that’s about to change. The

We all make bad hires. Learn the 5 reasons why we settle for B-players.

Your people are your company. Not your product pipeline, your regulatory clearances, your facility, or your capital. Your people. They

Cowboys vs. Ranchers in Ortho Sales

In ortho sales, we are told that people are divided into two groups: “hunters” who chase new business and “gatherers”

🔴 Tiger’s Red-Hot Innovator of the Week – Startup ushers in the Future of Joint Preservation with 3D-Printed, Lightweight Off-Loading Devices

Every Monday I share a startup that I really. I call it the Red-Hot Innovator of the Week. For decades,